Stock ABRT ALBERT LABS INTERNATIONAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Albert Labs International Corp.

Equities

ABRT

CA0127841041

Biotechnology & Medical Research

End-of-day quote Canadian Securities Exchange
Other stock markets
 06:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
0.015 CAD +50.00% Intraday chart for Albert Labs International Corp. -25.00% +50.00%
2023 Albert Labs International Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Albert Labs International Corp. Appoints Shabir Hasham to Its Board of Directors CI

Valuation

Fiscal Period: December 2022
Capitalization 1 2.727
Enterprise Value (EV) 1 2.647
P/E ratio -0.32 x
Yield -
Capitalization / Revenue -
EV / Revenue -
EV / EBITDA -639,787 x
EV / FCF -1,489,163 x
FCF Yield -0%
Price to Book -7.46 x
Nbr of stocks (in thousands) 68,163
Reference price 2 0.0400
Announcement Date 6/2/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022
Net sales - - -
EBITDA - -1.877 -4.138
EBIT 1 -1.733 -1.879 -4.141
Operating Margin - - -
Earnings before Tax (EBT) 1 -1.733 -1.879 -7.059
Net income 1 -1.733 -1.879 -7.059
Net margin - - -
EPS 2 -0.3023 -0.0473 -0.1251
Free Cash Flow - -0.3454 -1.778
FCF margin - - -
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 3/15/22 6/9/22 6/2/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022
Net Debt 1 - - -
Net Cash position 1 0.01 0.08 0.08
Leverage (Debt/EBITDA) - - -
Free Cash Flow - -0.35 -1.78
ROE (net income / shareholders' equity) - 1,553% 1,627%
ROA (Net income/ Total Assets) - -362% -993%
Assets 1 - 0.5192 0.7112
Book Value Per Share 2 0.0100 -0.0100 -0.0100
Cash Flow per Share 2 0 0 0
Capex - 0.14 0.06
Capex / Sales - - -
Announcement Date 3/15/22 6/9/22 6/2/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
ALBERT LABS INTERNATIONAL CORP. Stock Albert Labs International Corp.
+50.00% 815K
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ABRT Stock
  4. Financials Albert Labs International Corp.